Compounds > ml 9

ml 9 and Prostatic Neoplasms

ml 9 has been researched along with Prostatic Neoplasms in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (66.67)29.6817
2010's1 (33.33)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Dewailly, E; Gordienko, D; Kondratska, K; Kondratskyi, A; Lehen'kyi, V; Prevarskaya, N; Skryma, R; Slomianny, C; Yassine, M1
Jiraviriyakul, A; Phattarasakul, K; Sutthiphongchai, T; Tohtong, R1
Bradshaw, D; Murphy, C; Myers, CE; Ramos, S; Somlyo, AP; Somlyo, AV1

Other Studies

3 other study(ies) available for ml 9 and Prostatic Neoplasms

ArticleYear
Identification of ML-9 as a lysosomotropic agent targeting autophagy and cell death.
    Cell death & disease, 2014, Apr-24, Volume: 5

    Topics: Autophagy; Azepines; Calcium; Cell Line, Tumor; Class III Phosphatidylinositol 3-Kinases; Down-Regulation; Homeostasis; Humans; Hydrogen-Ion Concentration; Lysosomes; Male; Models, Biological; Phagosomes; Prostatic Neoplasms; Proto-Oncogene Proteins c-akt; TOR Serine-Threonine Kinases

2014
Dependence of metastatic cancer cell invasion on MLCK-catalyzed phosphorylation of myosin regulatory light chain.
    Prostate cancer and prostatic diseases, 2003, Volume: 6, Issue:3

    Topics: Adenocarcinoma; Animals; Azepines; Cell Division; Cell Line, Tumor; Cell Movement; Dose-Response Relationship, Drug; Male; Methotrexate; Myosin Light Chains; Myosin-Light-Chain Kinase; Naphthalenes; Neoplasm Invasiveness; Neoplasm Metastasis; Phosphorylation; Prostatic Neoplasms; Rats

2003
Rho-kinase inhibitor retards migration and in vivo dissemination of human prostate cancer cells.
    Biochemical and biophysical research communications, 2000, Mar-24, Volume: 269, Issue:3

    Topics: Amides; Animals; Azepines; Cattle; Cell Division; Cells, Cultured; Chemotaxis; Endothelium, Vascular; Enzyme Inhibitors; Humans; Intracellular Signaling Peptides and Proteins; Male; Mice; Mice, Transgenic; Myosin-Light-Chain Kinase; Myosin-Light-Chain Phosphatase; Neoplasm Invasiveness; Neoplasm Metastasis; Neovascularization, Physiologic; Phosphoprotein Phosphatases; Prostatic Neoplasms; Protein Serine-Threonine Kinases; Pyridines; rho-Associated Kinases; Transplantation, Heterologous; Tumor Cells, Cultured

2000